C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention

Cardiovascular Revascularization Medicine

Volumn 14, Issue 5, 2013, Pages 264-269

  Ndrepepa, Gjin ^a   Braun, Siegmund ^a   Cassese, Salvatore ^a   Fusaro, Massimiliano ^a   King, Lamin ^a   Kastrati, Adnan ^a   Schmidt, Roland ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

Author keywords

C reactive protein; Coronary artery disease; Gender; Mortality

Indexed keywords

C REACTIVE PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SMOKING;

C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; GENDER; MORTALITY;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; ROC CURVE; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84883786227     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2013.07.002     Document Type: Article

References (23)

1. Ridker P.M., Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med 1998, 46:391-395.
2. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
3. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group. Lancet 1997, 349:462-466.
4. Muhlestein J.B., Horne B.D., Carlquist J.F., Madsen T.E., Bair T.L., Pearson R.R., Anderson J.L. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000, 102:1917-1923.
5. Folsom A.R., Pankow J.S., Tracy R.P., Arnett D.K., Peacock J.M., Hong Y., Djousse L., Eckfeldt J.H. Investigators of the NFHS: association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001, 88:112-117.
6. Greenland P., Alpert J.S., Beller G.A., Benjamin E.J., Budoff M.J., Fayad Z.A., Foster E., Hlatky M.A., Hodgson J.M., Kushner F.G., Lauer M.S., Shaw L.J., Smith S.C., Taylor A.J., Weintraub W.S., Wenger N.K., Jacobs A.K., Smith S.C., Anderson J.L., Albert N., Buller C.E., Creager M.A., Ettinger S.M., Guyton R.A., Halperin J.L., Hochman J.S., Kushner F.G., Nishimura R., Ohman E.M., Page R.L., Stevenson W.G., Tarkington L.G., Yancy C.W. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010, 56:e50-103.
7. Lakoski S.G., Cushman M., Criqui M., Rundek T., Blumenthal R.S., D'Agostino R.B., Herrington D.M. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006, 152:593-598.
8. Cushman M., McClure L.A., Howard V.J., Jenny N.S., Lakoski S.G., Howard G. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem 2009, 55:1627-1636.
9. Cushman M., Arnold A.M., Psaty B.M., Manolio T.A., Kuller L.H., Burke G.L., Polak J.F., Tracy R.P. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study. Circulation 2005, 112:25-31.
10. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., Curhan G.C., Rifai N., Cannuscio C.C., Stampfer M.J., Rimm E.B. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004, 351:2599-2610.
11. Erbel R., Möhlenkamp S., Lehmann N., Schmermund A., Moebus S., Stang A., Grönemeyer D., Seibel R., Mann K., Volbracht L., Dragano N., Siegrist J., Jöckel K.H. Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis 2008, 197:662-672.
12. Emerging Risk Factors C, Kaptoge S., Di Angelantonio E., Lowe G., Pepys M.B., Thompson S.G., Collins R., Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
13. Emerging Risk Factors C, Kaptoge S., Di Angelantonio E., Pennells L., Wood A.M., White I.R., Gao P., Walker M., Thompson A., Sarwar N., Caslake M., Butterworth A.S., Amouyel P., Assmann G., Bakker S.J., Barr E.L., Barrett-Connor E., Benjamin E.J., Bjorkelund C., Brenner H., Brunner E., Clarke R., Cooper J.A., Cremer P., Cushman M., Dagenais G.R., D'Agostino R.B., Dankner R., Davey-Smith G., Deeg D., Dekker J.M., Engstrom G., Folsom A.R., Fowkes F.G., Gallacher J., Gaziano J.M., Giampaoli S., Gillum R.F., Hofman A., Howard B.V., Ingelsson E., Iso H., Jorgensen T., Kiechl S., Kitamura A., Kiyohara Y., Koenig W., Kromhout D., Kuller L.H., Lawlor D.A., Meade T.W., Nissinen A., Nordestgaard B.G., Onat A., Panagiotakos D.B., Psaty B.M., Rodriguez B., Rosengren A., Salomaa V., Kauhanen J., Salonen J.T., Shaffer J.A., Shea S., Ford I., Stehouwer C.D., Strandberg T.E., Tipping R.W., Tosetto A., Wassertheil-Smoller S., Wennberg P., Westendorp R.G., Whincup P.H., Wilhelmsen L., Woodward M., Lowe G.D., Wareham N.J., Khaw K.T., Sattar N., Packard C.J., Gudnason V., Ridker P.M., Pepys M.B., Thompson S.G., Danesh J. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012, 367:1310-1320.
14. Evrin P.E., Nilsson S.E., Oberg T., Malmberg B. Serum C-reactive protein in elderly men and women: association with mortality, morbidity and various biochemical values. Scand J Clin Lab Invest 2005, 65:23-31.
15. Tracy R.P., Arnold A.M., Ettinger W., Fried L., Meilahn E., Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999, 19:1776-1783.
16. Ndrepepa G., Braun S., King L., Fusaro M., Keta D., Cassese S., Tada T., Schomig A., Kastrati A. Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease. Am J Cardiol 2013, 111:804-810.
17. Khor L.L., Muhlestein J.B., Carlquist J.F., Horne B.D., Bair T.L., Maycock C.A., Anderson J.L. Intermountain Heart Collaborative Study G: sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Am J Med 2004, 117:657-664.
18. Garcia-Moll X., Zouridakis E., Cole D., Kaski J.C. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J 2000, 21:1598-1606.
19. Sandler H., Dodge H.T. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968, 75:325-334.
20. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
21. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W. Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
22. Garcia-Moll X., Coccolo F., Cole D., Kaski J.C. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000, 35:956-962.
23. Ndrepepa G., Braun S., von Beckerath N., Mehilli J., Gorchakova O., Vogt W., Schomig A., Kastrati A. Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease. Clin Chim Acta 2005, 360:178-186.